|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Apr 6, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||||||
| Cash | ||||||||||||||
| Other receivables | ||||||||||||||
| Prepaid expenses | ||||||||||||||
| Prepaid income tax | ||||||||||||||
| Total Current Assets | ||||||||||||||
| Cash held in the trust | ||||||||||||||
| Total assets | ||||||||||||||
| Current liabilities | ||||||||||||||
| Tax Payable | ||||||||||||||
| Accrued expenses | ||||||||||||||
| Other Payables | ||||||||||||||
| Income tax payable | ||||||||||||||
| Due to related parties | ||||||||||||||
| Franchise Tax Payable | ||||||||||||||
| Excise tax | ||||||||||||||
| Working capital loan | ||||||||||||||
| Extension loan | ||||||||||||||
| Due to related party | ||||||||||||||
| Advanced from related parties | ||||||||||||||
| Related Party | ||||||||||||||
| Total advanced from related parties | ||||||||||||||
| Advances from related parties | ||||||||||||||
| Related Party | ||||||||||||||
| Total advances from related parties | ||||||||||||||
| Redemption payable | ||||||||||||||
| Total Current liabilities | ||||||||||||||
| Deferred Underwriting Commission | ||||||||||||||
| Deferred Underwriting Commission | ||||||||||||||
| Total liabilities | ||||||||||||||
| Class A common stock subject to possible redemption; 4,395 shares issued and outstanding at redemption value of $13.01 per share and $11.38 per share at March 31, 2025 and December 31, 2024, respectively | ||||||||||||||
| Class A Common Stock | ||||||||||||||
| Total class A common stock subject to possible redemption; 4,395 shares issued and outstanding at redemption value of $13.01 per share and $11.38 per share at March 31, 2025 and December 31, 2024, respectively | ||||||||||||||
| Shareholders’ Deficit | ||||||||||||||
| Common stock, value | ||||||||||||||
| Class A Common Stock | ||||||||||||||
| Class B Common Stock | ||||||||||||||
| Total common stock, value | ||||||||||||||
| Class B common stock, par value $0.0001; 10,000,000 shares authorized; 2,587,500 issued and outstanding (1) on September 30, 2023 and December 31, 2022 | ||||||||||||||
| Accumulated deficit | ||||||||||||||
| Total stockholders’ deficit | ||||||||||||||
| Total liabilities and stockholders’ deficit | ||||||||||||||
Loading...
